Zhu H - Search Results

1

Bioinformatics Analysis for Constructing a Six-Immune-Related Long Noncoding RNA Signature as a Prognostic Model of Hepatocellular Carcinoma.

Wang J, Jin Z, Wu G, Wang J, Xu B, Zhu H, Guo Y, Wen Z. Wang J, et al. Among authors: zhu h. Biomed Res Int. 2022 Jul 7;2022:2093437. doi: 10.1155/2022/2093437. eCollection 2022. Biomed Res Int. 2022. PMID: 35845962 Free PMC article.

2

DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation.

Yang Z, Zhu H, Zhang L, Wei Q, Zhou L, Xu X, Song P, Liu J, Xie H, Zheng S. Yang Z, et al. Among authors: zhu h. Mol Biol Rep. 2020 Mar;47(3):1773-1782. doi: 10.1007/s11033-020-05271-3. Epub 2020 Feb 1. Mol Biol Rep. 2020. PMID: 32006198

3

ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.

Zhu H, Wang G, Zhu H, Xu A. Zhu H, et al. BMC Cancer. 2021 Mar 12;21(1):269. doi: 10.1186/s12885-021-07996-1. BMC Cancer. 2021. PMID: 33711961 Free PMC article.

4

Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma.

Wang W, Deng Z, Jin Z, Wu G, Wang J, Zhu H, Xu B, Wen Z, Guo Y. Wang W, et al. Among authors: zhu h. Medicine (Baltimore). 2022 Jan 28;101(4):e28694. doi: 10.1097/MD.0000000000028694. Medicine (Baltimore). 2022. PMID: 35089224 Free PMC article.

5

Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.

Zhu H, Jiang W, Zhu H, Hu J, Tang B, Zhou Z, He X. Zhu H, et al. Int J Oncol. 2022 May;60(5):51. doi: 10.3892/ijo.2022.5341. Epub 2022 Mar 22. Int J Oncol. 2022. PMID: 35315496 Free PMC article.

6

Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.

Chen J, Li Z, Jia X, Song W, Wu H, Zhu H, Xuan Z, Du Y, Zhu X, Song G, Dong H, Bian S, Wang S, Zhao Y, Xie H, Zheng S, Song P. Chen J, et al. Among authors: zhu h, zhu x. Oncogene. 2022 May;41(22):3118-3130. doi: 10.1038/s41388-022-02274-1. Epub 2022 Apr 27. Oncogene. 2022. PMID: 35477750

7

Methylation site APC112043544 as a potential biomarker for post-transplant hepatocellular carcinoma recurrence.

Yang Z, Chen W, Zhu H, Zhang L, Zhou K, Tang H, Sun R, Huang Y, Xie H, Zheng S, Jia C. Yang Z, et al. Among authors: zhu h. Future Oncol. 2022 Jun;18(19):2401-2413. doi: 10.2217/fon-2021-1608. Epub 2022 May 3. Future Oncol. 2022. PMID: 35502765

8

First Robotic Hepatectomy With Middle Hepatic Vein Reconstruction Using ePTFE Graft for Hepatic Adenoma: A Case Report.

Wang J, Jin Z, Xu B, Chen W, Zhang J, Zhu H, Lu T, Zhang L, Guo Y, Wen Z. Wang J, et al. Among authors: zhu h. Front Surg. 2022 Jun 14;9:904253. doi: 10.3389/fsurg.2022.904253. eCollection 2022. Front Surg. 2022. PMID: 35774390 Free PMC article.

9

Hepatectomy and pneumectomy combined with targeted therapy for primary hepatic neuroendocrine carcinoma: Case report and review of the literature.

Huang K, Lan Z, Chen W, Zhang J, Wang J, Zhu H, Xu B, Zhang L, Lu T, Guo Y, Wen Z. Huang K, et al. Among authors: zhu h. Front Surg. 2022 Jul 15;9:920276. doi: 10.3389/fsurg.2022.920276. eCollection 2022. Front Surg. 2022. PMID: 35910478 Free PMC article.

10

Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Jin Z, Wu G, Xu B, Wang J, Zhu H, Guo Y, Peng M, Peng T, Wen Z. Jin Z, et al. Among authors: zhu h. Front Surg. 2022 Sep 13;9:928452. doi: 10.3389/fsurg.2022.928452. eCollection 2022. Front Surg. 2022. PMID: 36176342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,433 results

Search Page

Filters